Check-Cap Ltd. (NASDAQ:CHEK) Sees Significant Decline in Short Interest

Check-Cap Ltd. (NASDAQ:CHEKGet Free Report) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 165,500 shares, a decline of 13.4% from the May 31st total of 191,100 shares. Approximately 3.8% of the company’s stock are sold short. Based on an average daily trading volume, of 247,400 shares, the days-to-cover ratio is presently 0.7 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Check-Cap in a research report on Wednesday, June 26th. They issued a “sell” rating on the stock.

Read Our Latest Research Report on CHEK

Check-Cap Price Performance

Shares of CHEK traded up $0.02 during midday trading on Monday, reaching $2.03. 53,370 shares of the stock were exchanged, compared to its average volume of 138,679. Check-Cap has a twelve month low of $1.78 and a twelve month high of $4.63. The company has a market capitalization of $11.88 million, a price-to-earnings ratio of -0.68 and a beta of 0.40. The business’s 50-day moving average price is $2.20 and its 200 day moving average price is $2.21.

Check-Cap (NASDAQ:CHEKGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The medical research company reported ($0.62) EPS for the quarter. As a group, equities research analysts expect that Check-Cap will post -0.68 earnings per share for the current fiscal year.

About Check-Cap

(Get Free Report)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.

Featured Articles

Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.